L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile

BACKGROUND: The newly developed Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) has consistently been shown to be prognostically significant in endometrial carcinomas (EC). Recently, we and others have demonstrated L1 cell-adhesion molecule (L1CAM) to be a significant indicator...

Descripción completa

Detalles Bibliográficos
Autores principales: Kommoss, Felix KF, Karnezis, Anthony N., Kommoss, Friedrich, Talhouk, Aline, Taran, Florin-Andrei, Staebler, Annette, Gilks, C. Blake, Huntsman, David G., Krämer, Bernhard, Brucker, Sara Y., McAlpine, Jessica N., Kommoss, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134076/
https://www.ncbi.nlm.nih.gov/pubmed/30050154
http://dx.doi.org/10.1038/s41416-018-0187-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134076/
https://www.ncbi.nlm.nih.gov/pubmed/30050154
http://dx.doi.org/10.1038/s41416-018-0187-6

Ejemplares similares